Detalhe da pesquisa
1.
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia.
Br J Haematol
; 190(6): 933-938, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439486
2.
Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib.
Ther Adv Hematol
; 12: 20406207211010875, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995988